Make your money go further for just 25p per day

PREMIUM
AIM IHT

Stunning results | Careful with the share class | Horrendous results

20/06/2024 · Alliance Pharma (APH)  · Intercede Group (IGP)  · Tatton Asset Management (TAM)  · Victoria (VCP)  · Young & Co. (YNGA) 

AIM AIM Inheritance Tax potential UK

Pub scene in the style of John Constable

News covered here includes our assessment of some stunning results from two AIM companies, both of which still have plenty of ambition. Elsewhere, potential investors in a popular pub group need to be careful which class of share they buy, while the long-awaited results from healthcare group lift the shares. Unfortunately, there was more questionable reporting from a flooring manufacturer which continues to be weighed down by a huge amount of debt.


Episode 22 of the Investor’s Champion Podcast

In this episode of the Investors Champion podcast, hosts Chris and Lee delve into several key topics shaping the UK investment landscape.

They start by celebrating the recent IPO of Raspberry Pi on the London Stock Exchange, highlighting the firm's market performance and its far-reaching applications. The conversation then transitions to Elon Musk's controversial pay deal and its potential implications for Tesla…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Alliance Pharma

AIM takeovers | Automotive excellence and struggles

01/10/2024 · Company Insights

One of AIM’s largest companies seems inclined to accept a private equity funded offer, with an…


Stunning results | Careful with the share class | Horrendous results

20/06/2024 · Company Insights

News covered here includes our assessment of some stunning results from two AIM companies, both of…


More on Intercede Group

Bonkers Bargain climbs | Murray mayhem | Cancellation crash

02/04/2025 · Company Insights

The prospect of far-reaching tariffs continues to dominate stock market sentiment and yet another AIM company…


Defence delights | Big dividends | Modest ratings

09/01/2025 · Company Insights

A small company covered here supporting the defence sector continues to do nicely, securing another important…


More on Tatton Asset Management

Defying the gloom | Selling-up | Bonkers Bargain update

16/04/2025 · Company Insights

The investment management sector has been going through times, but one company covered here has been…


Outrageous remuneration | Fabulous results | Cracking bargain

14/11/2024 · Company Insights

News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…


More on Victoria

Victoria delivers a train crash of results

28/11/2024 · Company Insights

News covered here includes our assessment of interim results from flooring specialists Victoria; we question whether…


Improving returns | Questionable business models

20/11/2024 · Company Insights

A software provider whose results we assess here continues to recover from the consequences of a…


More on Young & Co.

Grim greetings | Pub value | 10% dividend yield

17/01/2025 · Company Insights

News covered here includes our assessment of a positive Christmas trading update from a well-regarded and…


Outrageous remuneration | Fabulous results | Cracking bargain

14/11/2024 · Company Insights

News covered here includes our assessment of fabulous results from an AIM listed investment manager, which…


More Company Insights

Bonkers Bargain: encouraging trading update

16/04/2025 · IXICO

Bonkers Bargain: we mistimed our little gem

11/04/2025 · Gemfields

Sign-up to our free email updates

SIGN UP